Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors.
Kim YJ, Jang SK, Kim G, Hong SE, Park CS, Seong MK, Kim HA, Kim KS, Kim CH, Park KS, Hong J, Jin HO, Park IC.
Kim YJ, et al. Among authors: seong mk.
Anticancer Res. 2023 May;43(5):1973-1980. doi: 10.21873/anticanres.16357.
Anticancer Res. 2023.
PMID: 37097659